Published by Josh White on 30th October 2024
(Sharecast News) - GSK reported a mixed third-quarter performance on Wednesday, with a notable boost from specialty medicines helping to offset weaker sales in vaccines.
URL: http://www.digitallook.com/dl/news/story/34657213/...